Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $816.5100 (-0.78%) ($816.5100 - $816.5100) on Wed. Sep. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.74% (three month average) | RSI | 64 | Latest Price | $816.5100(-0.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(66%) IBB(61%) XLF(55%) DIA(54%) SDY(51%) | Factors Impacting REGN price | REGN will decline at least -0.87% in a week (0% probabilities). VXX(-44%) VIXM(-40%) TBT(-19%) USO(-18%) GLD(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.87% (StdDev 1.74%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $820.21 | 5 Day Moving Average | $826.46(-1.2%) | 10 Day Moving Average | $829.27(-1.54%) | 20 Day Moving Average | $820.21(-0.45%) | To recent high | -3.4% | To recent low | 17.9% | Market Cap | $86.573b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |